TrimRx's Blog
Wegovy Type 1 Diabetes — Safety, Risks & Alternatives
Wegovy isn’t approved for type 1 diabetes and poses serious risks. Learn the mechanisms, contraindications, and safer GLP-1 alternatives for T1D patients.
Cycling Off Wegovy — What Happens and How to Plan Ahead
Cycling off Wegovy leads to weight regain in most patients within 12 months. Learn the physiological mechanisms, timeline, and strategic protocols to
Weight Regain After Wegovy — Why It Happens & How to
Weight regain after Wegovy occurs in 60–70% of patients who stop treatment — here’s the hormonal mechanism behind it and the strategies that reduce
Wegovy Type 2 Diabetes — Does It Treat Blood Sugar or
Wegovy reduces A1C by up to 1.8% while delivering 15% weight loss at 68 weeks — but it’s FDA-approved for weight only, not diabetes treatment directly.
Wegovy Prediabetes — Does It Work Before You Have Diabetes?
Wegovy reduces prediabetes progression to type 2 diabetes by 73% in clinical trials. Here’s what that means for prevention, prescribing, and long-term use.
Wegovy Insulin Resistance — How GLP-1 Therapy Reverses It
Wegovy improves insulin resistance by activating GLP-1 receptors that restore beta-cell function and enhance glucose uptake — the mechanism works
Wegovy Obesity Treatment — Efficacy, Dosing & Real Results
Wegovy (semaglutide 2.4mg) delivers 14.9% mean weight loss in obesity treatment trials — here’s the dosing protocol, side effect timeline, and what most
Wegovy Cholesterol — Impact on Lipids & Heart Health
Wegovy reduces LDL cholesterol by 6–9% and triglycerides by 13–20% in clinical trials, independent of weight loss. Learn how the medication impacts
Wegovy Sleep Apnea — FDA Approval & Real Impact Results
Wegovy received FDA approval for obstructive sleep apnea in 2024, showing 25–35% reduction in AHI scores. How the GLP-1 mechanism works beyond weight loss
